Restricted accessResearch articleFirst published online 2025-08
Efficacy and Safety of Saururus chinensis Extract (LHF618) for Treating Allergic Rhinitis: A Randomized,Double-Blind,Placebo-Controlled,Multicenter Clinical Study
Allergic rhinitis (AR) has become a global health concern due to its increasing prevalence, significantly impacting the quality of life. Traditional treatment options often provide only temporary symptom relief and may cause adverse effects, leading to the exploration of alternative therapies. This study evaluates the effectiveness and safety of standardized Saururus chinensis extract (LHF618) for alleviating symptoms of AR. Over a 4-week period, patients receiving LHF618 showed significant reductions in total nasal symptom scores, particularly for symptoms such as nasal itching, sneezing, and congestion, compared with the control group. Additionally, LHF618 led to a marked improvement in rhinitis control assessment test scores and a significant reduction in specific immunoglobulin E levels related to dust mite allergens. Importantly, no significant adverse effects were observed, indicating that LHF618 is a well-tolerated and safe option. These findings suggest LHF618 could be a promising natural alternative for managing AR, especially in cases related to dust mite allergies.
Get full access to this article
View all access options for this article.
References
1.
MurrisonLB, BrandtEB, MyersJB, et al.Environmental exposures and mechanisms in allergy and asthma development. J Clin Invest, 2019; 129(4):1504–1515; doi: 10.1172/JCI124612
2.
BrożekJL, BousquetJ, AgacheI, et al.Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol, 2017; 140(4):950–958; doi: 10.1016/j.jaci.2017.03.050
3.
HaJ, LeeSW, YonDK. Ten-year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008-2017. Clin Exp Pediatr, 2020; 63(7):278–283; doi: 10.3345/cep.2019.01291
4.
LiS, WuW, WangG, et al.Association between exposure to air pollution and risk of allergic rhinitis: A systematic review and meta-analysis. Environ Res, 2022; 205:112472; doi: 10.1016/j.envres.2021.112472
OkuboK, KuronoY, IchimuraK, et al.; Japanese Society of Allergology. Japanese guidelines for allergic rhinitis 2020. Allergol Int, 2020; 69(3):331–345; doi: 10.1016/j.alit.2020.04.001
7.
LégerD, Annesi-MaesanoI, CaratF, et al.Allergic rhinitis and its consequences on quality of sleep: An unexplored area. Arch Intern Med, 2006; 166(16):1744–1748; doi: 10.1001/archinte.166.16.1744
HossenbaccusL, LintonS, GarveyS, et al.Towards definitive management of allergic rhinitis: Best use of new and established therapies. Allergy Asthma Clin Immunol, 2020; 16:39; doi: 10.1186/s13223-020-00436-y
10.
YooHJ, KangHJ, JungHJ, et al.Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Saururus chinensis extract. J Ethnopharmacol, 2008; 120(2):282–286; doi: 10.1016/j.jep.2008.08.016
11.
ZhangJ, RhoY, KimMY, et al.TAK1 in the AP-1 pathway is a critical target of Saururus chinensis (Lour.) Baill in its anti-inflammatory action. J Ethnopharmacol, 2021; 279:114400; doi: 10.1016/j.jep.2021.114400
12.
LeeE, HaaK, YookJM, et al.Anti-asthmatic activity of an ethanol extract from Saururus Chinensis. Biol Pharm Bull, 2006; 29(2):211–215; doi: 10.1248/bpb.29.211
13.
LeeYJ, KimJ, YiJM, et al.Anti-proliferative neolignans from Saururus chinensis against human cancer cell lines. Biol Pharm Bull, 2012; 35(8):1361–1366; doi: 10.1248/bpb.b110670
14.
LiB, LeeYJ, KimYC, et al.Sauchinone from Saururus chinensis protects vascular inflammation by heme oxygenase-1 induction in human umbilical vein endothelial cells. Phytomedicine, 2014; 21(2):101–108; doi: 10.1016/j.phymed.2013.08.009
15.
ChoHY, ChoCW, SongYS. Antioxidative and anti-inflammatory effects of Saururus chinensis methanol extract in RAW 264.7 macrophages. J Med Food, 2005; 8(2):190–197; doi: 10.1089/jmf.2005.8.190
16.
MoonSH, ChoiSW, ParkSJ, et al.In vitro and in vivo bone-forming activity of Saururus chinensis Extract. Phytother Res, 2015; 29(7):1073–1080; doi: 10.1002/ptr.5349
17.
SongM, LeeSY, KimM, et al.Saururus chinensis-controlled allergic pulmonary disease through NF-κB/COX-2 and PGE(2) pathways. PeerJ, 2020; 8:e10043; doi: 10.7717/peerj.10043
18.
LeeS-Y, ChoiC, ChoS-S, et al.Saururus chinensis water-extract effectively controls asthma by ameliorating of Th1/Th2 imbalance and suppressing of NF-κB/COX-2/PGE2-related inflammation. J Functional Foods, 2024; 112:105930; doi: 10.1016/j.jff.2023.105930
19.
U.S. Department of Health and Human Services. Food and Drug Administration, (CDER) CfDEaR. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Rockville, MD; 2005. Available from: https://www.fda.gov/media/72309/download [Last accessed: April8, 2022].
20.
KimM-A, YeY-M, BanG-Y, et al.Linguistic adaptation of the rhinitis control assessment test in Korean. Allergy Asthma Respir Dis, 2017; 5(4):205; doi: 10.4168/aard.2017.5.4.205
21.
DesrosiersM, DiamantZ, CastelnuovoP, et al.; SYNAPSE study investigators. Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up. Int Forum Allergy Rhinol, 2024; 14(1):18–31; doi: 10.1002/alr.23219
22.
VenneraMDC, SabadellC, PicadoC, Spanish Omalizumab Registry. Duration of the efficacy of omalizumab after treatment discontinuation in ‘real life’ severe asthma. Thorax, 2018; 73(8):782–784; doi: 10.1136/thoraxjnl-2017-210017
23.
MeltzerEO, SchatzM, NathanR, et al.Reliability, validity, and responsiveness of the rhinitis control assessment test in patients with rhinitis. J Allergy Clin Immunol, 2013; 131(2):379–386; doi: 10.1016/j.jaci.2012.10.022
24.
WangJ, ZhouY, ZhangH, et al.Pathogenesis of allergic diseases and implications for therapeutic interventions. Signal Transduct Target Ther, 2023; 8(1):138; doi: 10.1038/s41392-023-01344-4
25.
BraddingP, FeatherIH, WilsonS, et al.Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol, 1993; 151(7):3853–3865; doi: 10.4049/jimmunol.151.7.3853
ChoiDW, JungSY, KimGD, et al.Miquelianin inhibits allergic responses in mice by suppressing CD4(+) T cell proliferation. Antioxidants (Basel), 2021; 10(7); doi: 10.3390/antiox10071120
28.
IwasakiN, TerawakiS, ShimizuK, et al.Th2 cells and macrophages cooperatively induce allergic inflammation through histamine signaling. PLoS One, 2021; 16(3):e0248158; doi: 10.1371/journal.pone.0248158
29.
NaclerioRM. The role of histamine in allergic rhinitis. J Allergy Clin Immunol, 1990; 86(4 Pt 2):628–632; doi: 10.1016/s0091-6749(05)80227-1
30.
YamadaS, ShiraiM, InabaY, et al.Effects of repeated oral intake of a quercetin-containing supplement on allergic reaction: A randomized, placebo-controlled, double-blind parallel-group study. Eur Rev Med Pharmacol Sci, 2022; 26(12):4331–4345; doi: 10.2635/5/eurrev_202206_29072
31.
JungCH, LeeJY, ChoCH, et al.Anti-asthmatic action of quercetin and rutin in conscious guinea-pigs challenged with aerosolized ovalbumin. Arch Pharm Res, 2007; 30(12):1599–1607; doi: 10.1007/bf02977330
32.
MlcekJ, JurikovaT, SkrovankovaS, et al.Quercetin and its anti-allergic immune response. Molecules, 2016; 21(5); doi: 10.3390/molecules21050623
33.
ShaikYB, CastellaniML, PerrellaA, et al.Role of quercetin (a natural herbal compound) in allergy and inflammation. J Biol Regul Homeost Agents, 2006; 20(3–4):47–52
34.
KimHY, NamSY, HongSW, et al.Protective effects of rutin through regulation of vascular endothelial growth factor in allergic rhinitis. Am J Rhinol Allergy, 2015; 29(3):e87–e94; doi: 10.2500/ajra.2015.29.4195
35.
MillerJD. The role of dust mites in allergy. Clin Rev Allergy Immunol, 2019; 57(3):312–329; doi: 10.1007/s12016-018-8693-0
36.
SusantoAJ, RengganisI, RumendeCM, et al.The differences in serum quantitative specific IgE levels induced by dermatophagoides pteronyssinus, dermatophagoides farinae and blomia tropicalis sensitization in intermittent and persistent allergic asthma. Acta Med Indones, 2017; 49(4):299–306
37.
KimJH, YoonMG, SeoDH, et al.Detection of allergen specific antibodies from nasal secretion of allergic rhinitis patients. Allergy Asthma Immunol Res, 2016; 8(4):329–337; doi: 10.4168/aair.2016.8.4.329
38.
KimM, OhJH, ParkCY, et al.Dry eye disease and allergic conditions: A Korean nationwide population-based study. Am J Rhinol Allergy, 2016; 30(6):397–401; doi: 10.2500/ajra.2016.30.4361
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
